Revive Therapeutics's market cap is currently C$6.28M. The company's EPS TTM is C$-0.001; its P/E ratio is ―; Revive Therapeutics is scheduled to report earnings on May 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
